UroGen Pharma Ltd. (URGN) has 11 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 3 sales totalling $3.6M. Most recent filing: Sept. 9, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 9, 2026 filed Sept. 7, 2026 | Schoenberg Mark Chief Medical Officer | — | +796 | +1% | No | |
|
|
||||||
| Sept. 9, 2026 filed Sept. 7, 2026 | Smith Jason Drew General Counsel | — | +1,815 | +4% | No | |
|
|
||||||
| Aug. 24, 2026 filed Aug. 20, 2026 | Schoenberg Mark Chief Medical Officer | −$2,854,853 | 60,677 | −51% | No | |
|
|
||||||
| July 10, 2026 filed July 9, 2026 | Schoenberg Mark Chief Medical Officer | −$400,000 | 10,000 | −8% | Yes | |
|
|
||||||
| June 24, 2026 filed June 22, 2026 | Schoenberg Mark Chief Medical Officer | −$350,100 | 10,000 | −7% | Yes | |
|
|
||||||
Showing the 5 most recent of 11 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free